Cheng, M., P. H. Watson, et al. (1997) . "Pro-protein convertase gene expression in human breast cancer." Int J Cancer 71(6): 966-71. 31. Christinck, E. R., M. A. Luscher, et al. (1991). "Peptide binding to class I MHC on living cells and quantitation of comple xes required for CTL lysis." Nature 352(6330): 67-70. 32. Cohn, D. E., K. H. Kim, et al. (2011). "At what cost does a potential survival advantage of bevacizumab make sense fo r the primary treatment of ovarian cancer? A cost-effectiveness analysis." J Clin Oncol 29(10): 1247-51. 33. Coleman, S., A. Clayton, et al. (2005). "Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer." Cancer Res 65(15): 7000- 6. 34.